Group A | Group B | P-value | |
---|---|---|---|
N = 112 | N = 106 | ||
Age years, mean (SD) | 69.7 (11.5) | 75.7 (8.7) | <0.001 |
Men N (%) | 60 (53.6) | 63 (59.4) | 0.657 |
Obesity N (%) | 43 (38.7) | 34 (32.4) | 0.633 |
Hyperlipidemia N (%) | 37 (33.0) | 38 (35.9) | 0.892 |
Hypertension N (%) | 70 (62.5) | 83 (78.3) | 0.024 |
Diabetes mellitus N (%) | 33 (29.5) | 43 (40.6) | 0.172 |
Smoking (anytime) N (%) | 26 (23.4) | 41 (39.4) | 0.081 |
IACE therapy N (%) | 42 (37.5) | 43 (41.0) | 0.895 |
ARB therapy N (%) | 12 (10.71) | 20 (19.05) | 0.170 |
Statin therapy N (%) | 33 (23.7) | 51 (48.6) | 0.011 |
Pressure gradient across the aortic valve (mmHg); | |||
Mean ± SD | 44.4 ± 17.9 | 40.4 ± 15.5 | 0.128 |
Median (25th to 75th percentile) | 43 (32 to 57) | 41 (28 to 50) | |
Peak aortic valve velocity (m/s) | |||
Mean ± SD | 4.1 ± 0.8 | 4.0 ± 0.8 | 0.107 |
Median (25th to 75th percentile) | 4.2 (3.6 to 4.7) | 4.0 (3.4 to 4.4) | |
Severe aortic stenosis N (%) | 100 (89.3) | 85 (18.2) | 0.088 |